Liberty Leaf Holdings and Blox Labs To Develop Blockchain-Based Smart Contracts Ledger:
For The Legalized Cannabis Industry
Liberty Leaf Acquires the Majority Interest in Just Kush:
– a Late-Stage ACMPR Applicant and a Company in Control of a Current MMAR-Licensed Facility. The acquisition puts two ACMPR licences in play, strengthening Liberty Leaf’s strategic position as a forward-thinking, vertically-integrated cannabis company.
Liberty Leaf Strengthens Board of Directors:
with the Appointment of Doug Macdonell
Liberty Leaf Receives $763,500 from Exercise of Warrants:
We are very pleased with the level of support received from our shareholders as demonstrated by the recent exercise of warrants. With our significantly improved treasury, Liberty Leaf is well positioned to further advance its corporate initiatives.
Liberty Leaf Announces Newly Established Cannabis Advisory Board:
Appoints International Lawyer Robert W.E. Laurie as Chair
North Road Ventures retains Cannabis Compliance Inc. to usher in Application Abridgement to Health Canada:
The abridgment will increase the authorized distribution capacity of the company, as well as add new products to its application. North Road Ventures was acquired by Liberty Leaf on October 19, 2016, and focuses on distributing high-quality medicinal cannabis.
Liberty Leaf Appoints New CFO
Liberty Leaf is pleased to announce the appointment of Mr. Jamie Robinson as Chief Financial Officer of the Company, effective immediately.Mr. Robinson is a Chartered Accountant specializing in accounting, auditing and financial reporting under both IFRS and ASPE.
Liberty Leaf In Collaboration With ESEV R&D Launches Study To Demonstrate the Efficacy of CBD for Pain Management in Canine Osteoarthritis
Liberty Leaf announced today that it has finalized the statement of work model and design for testing the efficacy of Cannabinoids (CBD) in canine osteoarthritis, which includes hip dysplasia, elbow dysplasia and stifle Degenerative Joint Disease (DJD).
Liberty Leaf receives approval to be listed on the OTCQB Venture Market:
this furthers its strategy to engage and expand its U.S. investor audience. The company’s symbol on the OTCQB is LIBFF. It remains LIB on the CSE.
Liberty Leaf is added to the CSE Composite Index,
a unique gauge of the Canadian small cap market. The index is comprised of listed company shares that meet market capitalization, trading and seasoning criteria established by the Exchange.
Liberty Leaf enters into a Master Collaborative CBD Research Agreement
with Esev R&D LLC, a leading Israeli-American R&D company.
Liberty Leaf begins trading its common shares on the Frankfurt, Berlin, and Stuttgart Stock Exchanges
under the ticker symbol: HN3P and WKN: A2AT5C. These listings in provide the Company with increased exposure to some of the largest capital markets in the world and enable its European investor base to trade the Company’s common shares in their home currency.
Liberty Leaf receives an aggregate $650,325
from the exercise of share purchase warrants.
Weststar announces that the Company’s shares will begin trading on the CSE
on Friday, October 21, 2016 under the name Liberty Leaf Holdings Ltd. and symbol “LIB”.
Weststar receives shareholder approval
on the fundamental change of business and closes a non-brokered private placement financing for gross proceeds of more than $370,000.
Weststar announces a private placement of shares
bringing in gross proceeds of up to $250,000.
Weststar receives conditional approval from the Canadian Securities Exchange
on a Fundamental Change to the business concerning the purchase of North Road Ventures. The company also announces its intent to change its name to Liberty Leaf Holdings Ltd., and to change its stock symbol to “LIB”.
Weststar amends agreement to purchase shares of North Road Ventures Inc.,
by increasing its purchase interest to 100%, giving Weststar a 100% interest in North Road’s pending Marihuana for Medical Purposes Regulations (“MMPR”) application, as well as the option to participate in certain business opportunities that North Road now has or may have pending.
Weststar signs a definitive agreement to purchase shares of North Road Ventures Inc.,
a private British Columbia company, representing up to a 50% interest in North Road. This gives Weststar the opportunity to earn up to a 50% interest in North Road’s pending Marihuana for Medical Purposes Regulations (“MMPR”) application.
Weststar closes private placement financing
of $188,500 to fulfill the terms of a business arrangement with North Road Ventures Inc., and to assess other potential business opportunities and for general working capital.
Weststar closes oversubscribed financing
of $509,000 towards concluding a deal to purchase North Road Ventures, a company actively seeking a Health Canada Producer’s Licence. Note: as of 2017, producer licences are estimated to be worth $50 million.
Weststar explores business opportunities
in producing vaporizers and other accoutrements of cannabis use, such as glass pipes and grinders.